首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >SECTION 11. RADIOLOGICAL UTERVENTION to BnnHor COmpugations MTER LIVING DONOR HWER
【24h】

SECTION 11. RADIOLOGICAL UTERVENTION to BnnHor COmpugations MTER LIVING DONOR HWER

机译:第11节。居住者捐赠者对班戈尔夫妇的放射干预

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Although endoscopic treatment has become the first choice to treat biliary complications, percutaneous transhepatic treatment still has important roles to treat biliary stricture or leak after living donor liver transplantation. This study reviewed a total of 527 recipients who had undergone percutaneous transhepatic treatment to treat biliary stricture (n=498) and leaks (n=29). Percutaneous transhepatic treatment included percutaneous transhepatic biliary drainage, perihepatic biloma drainage, balloon dilation of biliary stricture, and drainage catheter interposition or retrievable covered stent placement across a stricture or leak segment. Clinical success was achieved in 440 (88.4%) recipients with biliary stricture and 19 (65.5%) recipients with bile leaks. Percutaneous transhepatic treatment seems to be an effective alternative for treating biliary complications resistant to or inaccessible by endoscopic treatment.
机译:尽管内镜治疗已成为治疗胆道并发症的首选方法,但经活体供肝移植后经皮经肝治疗仍对胆道狭窄或渗漏起着重要作用。这项研究回顾了总共527位接受过经皮经肝治疗以治疗胆道狭窄(n = 498)和渗漏(n = 29)的接受者。经皮经肝治疗包括经皮经肝胆道引流,肝周胆瘤引流,胆道狭窄的球囊扩张,引流导管置入或可取回的覆盖支架置入狭窄或渗漏段。 440例(88.4%)胆道狭窄患者和19例(65.5%)胆汁漏患者获得了临床成功。经皮肝穿刺治疗似乎是一种有效的替代方法,可治疗内镜治疗耐药或无法治疗的胆道并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号